News | April 09, 2026
OPPI and NIPER Raebareli partner to boost pharma research and talent
Scholarships, research grants and industry mentorship framework aim to strengthen India’s pharma R&D ecosystem
Scholarships, research grants and industry mentorship framework aim to strengthen India’s pharma R&D ecosystem
The initiative aligns with global psycho-oncology standards that advocate routine distress screening as a core quality benchmark in cancer treatment
Developed for today’s fast-paced, visually demanding lifestyles, the lenses are built on ZEISS NeurOptix technology
The trial demonstrated that immune responses in children were non-inferior to adults, with a similar safety profile after two standard doses of MVA-BN
The approval covers pediatric patients without a matched sibling donor for stem cell transplant
Beyond clinical trials, real-world evidence is adding weight to AbbVie’s claims
The company’s ACC lineup underscores a growing body of evidence backing the drug’s performance beyond controlled trials
The global, first-in-human, open-label trial will assess the safety, tolerability, pharmacokinetics, and preliminary anti-tumor activity of TRI-611
These approvals represent a defining moment for people living with classical Hodgkin Lymphoma
RSM01, a preventive treatment targeting respiratory syncytial virus (RSV), was licensed earlier this month from the Gates Medical Research Institute
Subscribe To Our Newsletter & Stay Updated
